Collectively, these results suggest that elevated IFN-γ expression by activated PBMCs and STAT1 activation in cancer cells play an important role in HER2 downregulation in cancer cells by the co-treatment of PBMCs and trastuzumab. Here, STAT1 is linked to cancer.